XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows from Operating Activities:    
Net loss $ (9,894,762) $ (11,681,435)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 102,660 709,057
Common stock issued for license agreement 0 596,302
Depreciation 2,898 2,321
Gain on disposal of fixed assets 0 (190)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (659,020) 537,925
Deferred offering costs (43,700) 0
Accounts payable and accrued expenses (267,413) (1,806,420)
Net cash used in operating activities (10,759,337) (11,642,440)
Cash Flows from Financing Activities:    
Payments of deferred offering costs 0 (56,750)
Payments on notes payable (266,762) (269,619)
Proceeds from exercise of warrants 3,627 21,326
Payments to stockholders for stock split rounding (2,043) 0
Proceeds from subscription receivable 882,539 0
Proceeds from sale of common stock and warrants, net 13,544,685 18,371,886
Net cash provided by financing activities 14,162,046 18,066,843
Net change in cash and cash equivalents 3,402,709 6,424,403
Cash and cash equivalents, at beginning of period 6,461,378 548,721
Cash and cash equivalents, at end of period 9,864,087 6,973,124
Supplemental disclosures of cash flow information:    
Cash paid for interest 12,509 13,346
Cash paid for income taxes 0 0
Supplemental disclosure of non-cash investing and financing activities:    
Prepaid insurance financed with note payable 31,040 0
Amortization of deferred offering costs $ 20,637 $ 232,677